DEL FAVERO, SIMONE
 Distribuzione geografica
Continente #
NA - Nord America 7.166
EU - Europa 1.614
AS - Asia 1.230
SA - Sud America 40
OC - Oceania 10
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.068
Nazione #
US - Stati Uniti d'America 7.145
SG - Singapore 622
IT - Italia 573
CN - Cina 394
DE - Germania 210
FR - Francia 195
FI - Finlandia 192
SE - Svezia 133
GB - Regno Unito 71
RU - Federazione Russa 71
VN - Vietnam 60
HK - Hong Kong 59
NL - Olanda 44
IN - India 39
ES - Italia 20
BR - Brasile 19
CH - Svizzera 18
CA - Canada 15
IE - Irlanda 14
UA - Ucraina 13
GR - Grecia 11
JP - Giappone 10
KR - Corea 10
PT - Portogallo 10
AT - Austria 9
CO - Colombia 9
IR - Iran 9
AU - Australia 8
LT - Lituania 7
MX - Messico 6
PE - Perù 6
BE - Belgio 5
NO - Norvegia 5
PK - Pakistan 5
BG - Bulgaria 4
DK - Danimarca 4
RO - Romania 4
EC - Ecuador 3
MY - Malesia 3
PH - Filippine 3
TW - Taiwan 3
BF - Burkina Faso 2
KE - Kenya 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
QA - Qatar 2
TH - Thailandia 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AZ - Azerbaigian 1
CL - Cile 1
EU - Europa 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
KH - Cambogia 1
KZ - Kazakistan 1
SA - Arabia Saudita 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 10.068
Città #
Fairfield 1.088
Woodbridge 625
Houston 624
Chandler 575
Ann Arbor 474
Ashburn 441
Seattle 400
Singapore 392
Cambridge 358
Wilmington 349
Santa Clara 284
Boardman 218
Padova 212
Princeton 138
Medford 133
Beijing 125
San Diego 121
Helsinki 113
Des Moines 105
Roxbury 60
Dong Ket 59
Hong Kong 53
Nanjing 36
Jacksonville 33
Frankfurt am Main 29
New York 29
London 26
Nuremberg 26
Providence 25
Milan 24
Modena 24
Falkenstein 21
Shenyang 20
Nanchang 19
Verona 16
Munich 15
Guangzhou 14
Redwood City 14
Dublin 12
Jiaxing 11
Zurich 11
Bagnolet 10
Falls Church 10
Amsterdam 9
Venice 9
Brooklyn 8
Chicago 8
Dearborn 8
Hebei 8
Jinan 8
Kharkiv 8
Los Angeles 8
Cedar Lake 7
Changsha 7
Gavirate 7
Ogden 7
Rome 7
Shanghai 7
Tianjin 7
Treviso 7
Borås 6
Cagliari 6
Charlottesville 6
Delhi 6
Kunming 6
Lima 6
Orange 6
São Paulo 6
Tokyo 6
Valencia 6
Zhengzhou 6
Aprilia 5
Bern 5
Council Bluffs 5
Hangzhou 5
Ningbo 5
Oberhaching 5
Parsippany 5
Pohang 5
Tehran 5
Trondheim 5
Vienna 5
Vilnius 5
Bristol 4
Florence 4
Granze 4
Grenoble 4
Kolkata 4
Lappeenranta 4
Loutsa 4
Napoli 4
Paris 4
Philadelphia 4
Prescot 4
Rovereto 4
San Francisco 4
Santa Cruz 4
Scafati 4
Vicenza 4
Acton 3
Totale 7.695
Nome #
2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: A randomised crossover trial 170
Data-Driven Anomaly Recognition for Unsupervised Model-Free Fault Detection in Artificial Pancreas 162
Accuracy of a CGM Sensor in Pediatric Subjects With Type 1 Diabetes. Comparison of Three Insertion Sites: Arm, Abdomen, and Gluteus 148
A Glucose-Specific Metric to Assess Predictors and Identify Models 144
Randomized summer camp crossover trial in 5-to 9-year-old children: Outpatient wearable artificial pancreas is feasible and safe 144
Multinight "Bedside" closed-loop control for patients with type 1 diabetes 138
Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes 131
Parental evaluation of a telemonitoring service for children with Type 1 Diabetes 131
Individually Adaptive Artificial Pancreas in Subjects with Type 1 Diabetes: A One-Month Proof-of-Concept Trial in Free-Living Conditions 130
A personalized and interpretable deep learning based approach to predict blood glucose concentration in type 1 diabetes 128
Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas. 127
On the discardability of data in Support Vector Classification problems 126
A Real-Time Continuous Glucose Monitoring Based Algorithm to Trigger Hypotreatments to Prevent/Mitigate Hypoglycemic Events 119
A majorization inequality and its application to distributed Kalman filtering 116
Model of glucose sensor error components: identification and assessment for new Dexcom G4 generation devices. 113
Consensus-based distributed sensor calibration and least-square parameter identification in wsns. 113
Model individualization for artificial pancreas 111
Modular Closed-Loop Control of Diabetes. 111
Day and night closed-loop control in adults with type 1 diabetes: a comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management. 108
A distributed solution to estimation problems in wireless sensor networks leveraging broadcast communication. 106
Fully Integrated Artificial Pancreas in Type 1 Diabetes: Modular Closed-Loop Glucose Control Maintains Near Normoglycemia. 105
null 104
Bayesian learning of probability density functions: a Markov chain Monte Carlo approach 102
Modeling transient disconnections and compression artifacts of continuous glucose sensors 101
Assessment of patient perceptions about web telemonitoring applied to artificial pancreas use at home 99
Day-and-night closed-loop glucose control in patients with type 1 diabetes under free-living conditions:results of a single-arm 1-month experience compared with a previously reported feasibility study of evening and night at home 99
First Use of Model Predictive Control in Outpatient Wearable Artificial Pancreas 99
Remote blood glucose monitoring in mHealth scenarios: A review 98
Detecting failures of the glucose sensor-insulin pump system: improved overnight safety monitoring for Type-1 diabetes. 97
Real-time detection of glucose sensor and insulin pump faults in an artificial pancreas 97
Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin Delivery 97
Pilot Studies of Wearable Outpatient Artificial Pancreas in Type 1 Diabetes 96
Safety of Outpatient Closed-Loop Control: First Randomized Crossover Trials of a Wearable Artificial Pancreas 96
Finding Potential Support Vectors in Separable Classification Problems 95
Overnight Closed-Loop Control Improves Glycemic Control in a Multicenter Study of Adults With Type 1 Diabetes 92
Comparing Different Individualized Black-Box Models for Insulin Pump Faults Detection on Artificial Pancreas Data 92
Distributed Estimation through Randomized Gossip Kalman Filter 91
Distributed Kalman smoothing in static Bayesian networks 90
Psychological outcomes of evening and night closed-loop insulin delivery under free living conditions in people with Type 1 diabetes: a 2-month randomized crossover trial 89
Multinational home use of closed-loop control is safe and effective 88
Multicenter Outpatient Wearable Artificial Pancreas (AP) Study: Improved Safety and Efficacy of Glycemic Control 88
Closing the Loop 88
A novel nonparametric approach for the identification of the glucose-insulin system in Type 1 diabetic patients 87
Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites. 87
Distributed sensor calibration and least-square parameter identification in WSNs using consensus algorithms 86
An Online Failure Detection Method of the Glucose Sensor-Insulin Pump System: Improved Overnight Safety of Type-1 Diabetic Subjects 84
On-line calibration of glucose sensors from the measured current by a time-varying calibration function and Bayesian priors 82
A Bayesian Framework to Identify Type 1 Diabetes Physiological Models Using Easily Accessible Patient Data 82
Modeling the Glucose Sensor Error 81
Analysis of a Minimal Gene Regulatory Network for Cell Differentiation 81
Fault Detection in Artificial Pancreas: A Model-Free approach 81
Model-Based Detection and Classification of Insulin Pump Faults and Missed Meal Announcements in Artificial Pancreas Systems for Type 1 Diabetes Therapy 81
An analytical approach to determine the optimal duration of continuous glucose monitoring data required to reliably estimate time in hypoglycemia 80
Machine-Learning Based Model to Improve Insulin Bolus Calculation in Type 1 Diabetes Therapy 79
The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability 78
Gene selection for optimal prediction of cell position in tissues from single-cell transcriptomics data 77
Modeling Carbohydrate Counting Error in Type 1 Diabetes Management 76
From in - To out-patient Artificial Pancreas studies: Results and new developments 75
Il pancreas artificiale in età  pediatrica: Prima esperienza Italiana 75
Reduction of Hyper- and Hypoglycemia during Two Months with a Wearable Artificial Pancreas from Dinner to Breakfast in Patients with Type 1 Diabetes 73
Retrofitting Real-Life Dexcom G5 Data 71
Detection of Insulin Pump Malfunctioning to Improve Safety in Artificial Pancreas Using Unsupervised Algorithms 68
PREDIABETES AND TYPE 2 DIABETES SIMULATOR: IN SILICO TESTING OF NEW DRUGS. DIABETES TECHNOLOGY & THERAPEUTICS 66
MULTI-CENTER RANDOMIZED CROSS-OVER ITALIAN PEDIATRIC SUMMER CAMP: AP VS SAP IN 5-9 YEAR OLD CHILDREN 66
Analysis and Development of Consensus-based Estimation Schemes 66
Mathematical Models of Meal Amount and Timing Variability With Implementation in the Type-1 Diabetes Patient Decision Simulator 65
The Multi-Modular Model Predictive Control-to-Range (MPC2R) Allows Simultaneous Improvement in Safety and Efficacy of Closed-Loop Insulin Delivery in Type 1 Diabetes (T1D) 64
Glucose-insulin model identified in free-living conditions for hypoglycaemia prevention 64
A new real-time algorithm for preventive hypotreatments generation allows reducing frequency and duration of hypoglycemia 64
Retrofitting of Continuous Glucose Monitoring Traces Allows More Accurate Assessment of Glucose Control in Outpatient Studies 63
Artificial Pancreas Improves Glycemic Control in a Multi-night Multicenter Outpatient/Home Study of Patients with T1D 62
Improving accuracy and precision of glucose sensor profiles: Retrospective fitting by constrained deconvolution 62
Designing an artificial pancreas architecture: the AP@home experience 61
Supervised Learning-based Detection of Pressure-induced Failures in Continuous Glucose Sensors 60
Method to Improve Safety Monitoring in Type-1 Diabetic Patients by Detecting in Real-Time Failures of the Glucose Sensor-Insulin Pump System 60
PERCEIVED UTILITY OF A REMOTE MONITORING SYSTEM FOR PEDIATRIC SUBJECTS AFFECTED BY TYPE 1 DIABETES IN PEDARPAN (PEDIATRICS ARTIFICIAL PANCREAS) SUMMER CAMP 59
SUPPORT VECTOR REGRESSION FOR MID-TERM NOCTURNAL GLUCOSE PREDICTION FROM CONTINUOUS GLUCOSE MONITORING AND INSULIN DELIVERY INFORMATION 58
Psychological aspects of evening and night closed-loop insulin delivery under free living conditions: a 2 months cross-over trial 58
Deployment of modular MPC for type 1 diabetes control: The Italian experience 2008-2016 58
THE SOCIAL ACCEPTANCE OF FUTURE ARTIFICIAL PANCREAS TECHNOLOGY: PARENTS' PERCEPTIONS OF PEDARPAN (PEDIATRICS ARTIFICIAL PANCREAS) 57
Limits of Correlation Coefficient Analysis in Determining the Minimal Duration of CGM Data Needed to Estimate Time Below Range 57
Determining the Optimal Duration of a Clinical Trial having Time-in-ranges as Final Endpoints 57
A Mathematical Formula to Determine the Minimum Continuous Glucose Monitoring Duration to Assess Time-in-ranges: Sensitivity Analysis Over the Parameters 57
DETECTION OF GLUCOSE-SENSOR AND INSULIN-PUMPS FAILURES: FROM OVERNIGHT TO NIGHT \& DAY 55
MODEL OF CGM ERROR FROM MULTIPLE SENSOR DATA: DISSECTION INTO PHYSIOLOGICAL AND TECHNOLOGICAL COMPONENTS 54
Retrospective retrofitting method to generate a continuous glucose concentration profile by exploiting continuous glucose monitoring sensor data and blood glucose 53
A Bayesian framework to personalize glucose prediction in type 1 diabetes using a physiological model 53
Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites. 52
A new CGM-based algorithm to generate preventive hypotreatments: an in-silico assessment 52
Ablation catheter orientation: In vitro effects on lesion size and in vivo analysis during PVI for atrial fibrillation 52
HbA(1c) improvement with less hypoglycaemia in patients with type 1 diabetes wearing an artificial pancreas for two months from dinner to breakfast 51
A real-time continuous glucose monitoring based algorithm to trigger carbohydrates assumption to prevent/mitigate hypoglycemic events 50
In-silico Assessment of Preventive Hypotreatment Efficacy and Development of a Continuous Glucose Monitoring Based Algorithm to Prevent/Mitigate Hypoglycemia in Type 1 Diabetes 50
CALIBRATION OF GLUCOSE SENSORS: USE OF A TIME-VARYING CALIBRATION FUNCTION AND BAYESIAN PRIORS 49
Development and in-silico assessment of a CGM-based approach to trigger assumption of hypotreatments 49
Forecasting of glucose levels and hypoglycemic events: Head-to-head comparison of linear and nonlinear data-driven algorithms based on continuous glucose monitoring data only 49
Impact of Carbohydrate Counting Error on Glycemic Control in Open-Loop Management of Type 1 Diabetes: Quantitative Assessment Through an in silico Trial 49
Linear Model Identification for Personalized Prediction and Control in Diabetes 49
Modeling the error of factory-calibrated continuous glucose monitoring sensors: Application to Dexcom G6 sensor data 48
Improving Overnight Safety of Type 1 Diabetes Subjects: Failure Detection Method of Glucose Sensor–Insulin Pumps System Based on an Average Model 47
Totale 8.409
Categoria #
all - tutte 45.172
article - articoli 25.848
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 767
selected - selezionate 0
volume - volumi 678
Totale 72.465


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020462 0 0 0 0 0 0 0 0 145 154 108 55
2020/20211.380 58 46 26 85 123 88 86 111 216 178 227 136
2021/20221.775 51 199 196 47 103 156 106 248 112 30 152 375
2022/20231.342 279 99 61 102 220 157 14 84 176 33 79 38
2023/2024922 57 145 118 82 65 63 60 39 28 58 102 105
2024/20251.938 32 308 185 160 546 84 249 324 50 0 0 0
Totale 10.378